NAD+ Injections

Nicotinamide adenine dinucleotide (NAD+) is a molecule involved in cellular energy processes. Injectable compounded NAD+ is marketed for wellness purposes, but evidence for many claimed benefits remains limited.

• After discussing the limited evidence, alternatives, and individual health goals.
• Only when a provider determines a compounded prescription is appropriate.

NAD+ participates in cellular energy transfer and other metabolic pathways. This biological role does not establish that supplemental injections treat or prevent disease.

• Provider assessment before treatment.
• Formulation-specific use instructions.
• No guaranteed energy, longevity, or performance results.

Injection as directed by the prescriber. Use only according to the exact instructions supplied by your prescribing provider and dispensing pharmacy.

The IV Code does not publish generalized dosing because instructions depend on the individual, prescription, and dispensed formulation.

• People who are pregnant or breastfeeding, have ingredient allergies, or have significant medical conditions require individualized review.

Compounded medications are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality in the same manner as FDA-approved drugs. A licensed provider evaluates each patient; a prescription is not guaranteed. Compounded treatment should be prescribed only when the provider determines it is appropriate for the individual patient and applicable legal requirements are satisfied. Cost or preference alone does not establish medical necessity for compounding.

A compounded medication is not the same thing as an FDA-approved generic drug.